Stock listing
CSE:BETR BetterLife Pharma Inc. Stock
Home listing (CSE) of BetterLife Pharma Inc.
Follow BetterLife Pharma Inc. into a list and get an email when it puts out news.
Share price · CSE:BETR
$0.185 CAD -0.020 (-9.8%)
Close on Nov 20, 2026
- Day range
- $0.185 – $0.200 CADNov 20, 2026
- Volume
- 105,700 sharesNov 20, 2026
- Market cap
- $120.5M CADAt the close on Nov 20, 2026 · price × 651.3M shares outstanding
- 52-week range
- $0.040 – $0.460 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $116,452 CADMedian day 256,309 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:BETR · Home | $0.185 CAD | -0.020 (-9.8%) | 105,700 | $0.190 | $0.200 | $0.185 | $0.205 | Close on Nov 20, 2026 |
| OTC:BETRF | $0.139 USD | -0.002 (-1.3%) | 2,500 | $0.133 | $0.139 | $0.133 | $0.141 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · CSE:BETR · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.185 | -0.020 | -9.8% | $0.190 | $0.200 | $0.185 | 105,700 | |
| $0.205 | -0.005 | -2.4% | $0.185 | $0.220 | $0.180 | 219,507 | |
| $0.210 | +0.010 | +5.0% | $0.215 | $0.225 | $0.200 | 609,125 | |
| $0.200 | 0.000 | 0.0% | $0.200 | $0.220 | $0.185 | 107,000 | |
| $0.200 | -0.015 | -7.0% | $0.200 | $0.200 | $0.200 | 550 | |
| $0.215 | +0.010 | +4.9% | $0.200 | $0.215 | $0.200 | 31,620 | |
| $0.205 | +0.015 | +7.9% | $0.195 | $0.205 | $0.195 | 268,500 | |
| $0.190 | -0.015 | -7.3% | $0.200 | $0.215 | $0.180 | 2,098,071 | |
| $0.205 | -0.020 | -8.9% | $0.220 | $0.225 | $0.205 | 161,500 | |
| $0.225 | +0.005 | +2.3% | $0.230 | $0.230 | $0.210 | 341,300 | |
| $0.220 | -0.010 | -4.3% | $0.220 | $0.220 | $0.215 | 118,666 | |
| $0.230 | +0.005 | +2.2% | $0.225 | $0.230 | $0.215 | 128,554 | |
| $0.225 | -0.015 | -6.2% | $0.240 | $0.240 | $0.220 | 622,500 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 142,106 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.245 | 750,847 | |
| $0.250 | +0.010 | +4.2% | $0.245 | $0.260 | $0.245 | 144,000 | |
| $0.240 | +0.015 | +6.7% | $0.235 | $0.250 | $0.235 | 116,021 | |
| $0.225 | 0.000 | 0.0% | $0.230 | $0.230 | $0.220 | 16,600 | |
| $0.225 | 0.000 | 0.0% | $0.230 | $0.235 | $0.225 | 248,100 | |
| $0.225 | -0.020 | -8.2% | $0.240 | $0.240 | $0.225 | 345,435 | |
| $0.245 | -0.005 | -2.0% | $0.250 | $0.260 | $0.230 | 501,610 | |
| $0.250 | +0.050 | +25.0% | $0.210 | $0.285 | $0.210 | 2,032,641 | |
| $0.200 | -0.010 | -4.8% | $0.210 | $0.215 | $0.200 | 144,800 | |
| $0.210 | 0.000 | 0.0% | $0.210 | $0.225 | $0.210 | 116,326 | |
| $0.210 | -0.015 | -6.7% | $0.230 | $0.230 | $0.210 | 467,301 | |
| $0.225 | +0.005 | +2.3% | $0.225 | $0.230 | $0.220 | 132,057 | |
| $0.220 | -0.025 | -10.2% | $0.250 | $0.250 | $0.220 | 456,300 | |
| $0.245 | -0.010 | -3.9% | $0.260 | $0.260 | $0.245 | 300,607 | |
| $0.255 | -0.015 | -5.6% | $0.280 | $0.280 | $0.255 | 314,343 | |
| $0.270 | +0.010 | +3.8% | $0.260 | $0.270 | $0.250 | 311,500 | |
| $0.260 | -0.005 | -1.9% | $0.260 | $0.270 | $0.260 | 129,967 | |
| $0.265 | -0.025 | -8.6% | $0.295 | $0.295 | $0.265 | 269,089 | |
| $0.290 | +0.025 | +9.4% | $0.290 | $0.290 | $0.270 | 30,701 | |
| $0.265 | -0.005 | -1.9% | $0.270 | $0.285 | $0.265 | 372,951 | |
| $0.270 | -0.075 | -21.7% | $0.315 | $0.320 | $0.270 | 921,958 | |
| $0.345 | +0.060 | +21.1% | $0.300 | $0.345 | $0.290 | 73,010 | |
| $0.285 | -0.025 | -8.1% | $0.315 | $0.315 | $0.285 | 283,489 | |
| $0.310 | -0.025 | -7.5% | $0.330 | $0.330 | $0.305 | 319,050 | |
| $0.335 | -0.015 | -4.3% | $0.350 | $0.355 | $0.330 | 198,701 | |
| $0.350 | +0.015 | +4.5% | $0.335 | $0.350 | $0.335 | 184,428 | |
| $0.335 | +0.015 | +4.7% | $0.335 | $0.345 | $0.330 | 181,700 | |
| $0.320 | +0.015 | +4.9% | $0.320 | $0.330 | $0.305 | 209,113 | |
| $0.305 | -0.025 | -7.6% | $0.335 | $0.350 | $0.300 | 1,535,561 | |
| $0.330 | -0.030 | -8.3% | $0.355 | $0.360 | $0.330 | 248,618 | |
| $0.360 | 0.000 | 0.0% | $0.350 | $0.390 | $0.340 | 861,522 | |
| $0.360 | -0.020 | -5.3% | $0.390 | $0.390 | $0.350 | 505,800 | |
| $0.380 | -0.020 | -5.0% | $0.400 | $0.400 | $0.360 | 392,698 | |
| $0.400 | +0.060 | +17.6% | $0.340 | $0.400 | $0.340 | 1,124,392 | |
| $0.340 | +0.035 | +11.5% | $0.315 | $0.340 | $0.315 | 184,786 | |
| $0.305 | +0.005 | +1.7% | $0.300 | $0.310 | $0.300 | 264,000 | |
| $0.300 | -0.005 | -1.6% | $0.305 | $0.305 | $0.300 | 44,015 | |
| $0.305 | +0.005 | +1.7% | $0.305 | $0.305 | $0.300 | 31,533 | |
| $0.300 | 0.000 | 0.0% | $0.305 | $0.305 | $0.300 | 615,167 | |
| $0.300 | +0.015 | +5.3% | $0.285 | $0.310 | $0.280 | 892,540 | |
| $0.285 | -0.005 | -1.7% | $0.295 | $0.295 | $0.280 | 195,000 | |
| $0.290 | 0.000 | 0.0% | $0.310 | $0.310 | $0.280 | 116,316 | |
| $0.290 | -0.025 | -7.9% | $0.325 | $0.325 | $0.290 | 854,369 | |
| $0.315 | +0.005 | +1.6% | $0.345 | $0.345 | $0.290 | 590,644 | |
| $0.310 | -0.060 | -16.2% | $0.350 | $0.355 | $0.300 | 2,554,040 | |
| $0.370 | -0.010 | -2.6% | $0.375 | $0.380 | $0.350 | 39,195 | |
| $0.380 | +0.060 | +18.8% | $0.320 | $0.380 | $0.300 | 441,701 | |
| $0.320 | -0.005 | -1.5% | $0.320 | $0.320 | $0.295 | 238,893 | |
| $0.325 | +0.010 | +3.2% | $0.320 | $0.330 | $0.300 | 266,880 | |
| $0.315 | -0.035 | -10.0% | $0.315 | $0.340 | $0.310 | 169,019 |
- Ticker
- CSE:BETR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news release · Nov 20, 2026
BetterLife Pharma Engages Market Maker
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 18 slides
Latest news
BetterLife Pharma Engages Market Maker
Nov 20, 2026
Closed $0.185 (-9.8%) on Nov 20, 2026
BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026
Nov 17, 2026
Closed $0.21 (+5.0%) on Nov 17, 2026
BetterLife Pharma Announces Stock Option Grant
Nov 17, 2026
Closed $0.21 (+5.0%) on Nov 17, 2026
BetterLife Pharma Announces Settlement of Claim with Dr. Steven Sangha
Nov 6, 2026
Closed $0.225 (+2.3%) on Nov 6, 2026
2026-11-05 BETR – Board Changes FINAL
Nov 5, 2026
Closed $0.22 (-4.3%) on Nov 5, 2026
BetterLife Pharma Appoints Henry Chow, CPA, CA, to Board of Directors
Nov 5, 2026
Closed $0.22 (-4.3%) on Nov 5, 2026
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
Oct 27, 2026
Closed $0.225 (0.0%) on Oct 27, 2026
BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
Oct 19, 2026
Closed $0.21 (0.0%) on Oct 19, 2026
BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations
Oct 15, 2026
Closed $0.225 (+2.3%) on Oct 15, 2026
BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair
Oct 14, 2026
Closed $0.22 (-10.2%) on Oct 14, 2026
Financings
Public offering of common shares and pre-funded warrants
Sep 17, 2026
Closed: US$100M raised · C$0.25 a share · Bloom Burton Securities Inc. +1
Dealers: Bloom Burton Securities Inc. (lead), Haywood Securities Inc.
Buyers: Deep Track Capital (led the financing); Coastlands Capital (significant co-investment); Marshall Wace (significant co-investment); RA Capital Management (significant co-investment); Perceptive Advisors (significant co-investment); Adage Capital Management (participation); Affinity Asset Advisors (participation); Kalehua Capital (participation); Sphera Fund Management (participation); Squadron Capital Management (participation); Stonepine Capital Management (participation); Woodline Partners LP (participation)
Use of proceeds: Phase 1A, Phase 1B and Phase 2 clinical trials of BETR-001 in cluster headache and migraine, plus working capital and general corporate purposes
Announced Aug 24, 2026 · Terms changed Aug 28, 2026 · Closed Sep 17, 2026
Convertible debenture
Jun 22, 2026 · US$1.41M
Closed: C$2M raised · C$0.06 · 1 warrant at C$0.1 for 36 months
Insiders: A director and insider of the Company subscribed for $2,000,000 of the Debenture; conversion subject to a 19.9% ownership cap absent shareholder approval
Use of proceeds: Complete remaining IND-enabling activities for BETR-001 and general working capital
Warrant exercise of common shares on exercise of share purchase warrants
May 6, 2025 · US$18,138
Closed: C$25,000 raised
Decks
Investor Presentation (July 2026)
Investor deck · 18 slides · July 2026
Investor Presentation (January 2023)
Investor deck · 15 slides · Jan 13, 2023
Investor Presentation (August 2022)
Investor deck · 15 slides · August 2022
Investor Presentation (December 2021)
Investor deck · 23 slides · December 2021
BetterLife Pharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 86 in all · newest Nov 20, 2026 · oldest 2017
- Decks
- 5 decks · latest July 2026
Where BetterLife Pharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:BETR · Home listing · This page | CSE | Canada | CAD |
| OTC:BETRF | OTC | United States | USD |
| Cboe Canada:BETR | Cboe Canada | Canada | CAD |
| Frankfurt:NPAU | Frankfurt | Germany | EUR |
| LS Exchange:A2P7XN | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2P7XN | Lang & Schwarz | Germany | EUR |
| gettex:NPAU | gettex | Germany | EUR |
| Stuttgart:NPAU | Stuttgart | Germany | EUR |
| Munich:NPAU | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about BetterLife Pharma Inc.